维普中文期刊产品整合服务
1773篇 您的检索式:作者名="WRIGHT B"
    题名 作者 年代 出处 被引量
1Progress in carbon dioxide separation and capture: A review显示文摘这篇文章考察在 CO2 分离和俘获研究和工程取得的进步。各种各样的技术例如吸收,吸附,和膜分离,彻底地被讨论。象化学循环的燃烧和基于水合物的分离那样的新概念也简短被介绍。未来方向被建议。隐遁方法海洋授精和矿物质碳酸饱和技术例如造林,也被盖住。地下的注射和直接海洋垃圾场没被盖住。Hongqun Yang Zhenghe Xu Maohong Fan Rajender Gupta Rachid B Slimane Alan E Bland Ian Wright 2008Journal of Environmental Sciences2008,20,1:89
2基于随机暴雨移置方法的城市设计暴雨分析显示文摘城市地区暴雨洪灾发生频繁,合理计算设计暴雨是解决城市洪涝的重要前提。采用随机暴雨移置方法(Stochastic Storm Transposition,SST),设定暴雨移置区并提取出暴雨目录,通过区域性概率重采样与暴雨空间变换相结合的方式进行降雨频率分析,估计本地化的极端暴雨频率。以上海地区为例,研究发现暴雨移置区内暴雨分布具有空间异质性,暴雨随机移置概率不均,计算得到的设计暴雨方案包含了降雨时空分布信息,在不同重现期下设计暴雨的时空结构存在变异性,说明传统方法中采用的简化雨型和均一化空间分布假设会增加设计暴雨的不确定性。周正正 刘曙光 Daniel B Wright 2020水科学进展2020,31,4:6
3Intravenous immune globulin suppresses angiogenesis in mice and humans显示文摘Human intravenous immune globulin(IVIg),a purified IgG fraction composed of~60%IgG1 and obtained from the pooled plasma of thousands of donors,is clinically used for a wide range of diseases.The biological actions of IVIg are incompletely understood and have been attributed both to the polyclonal antibodies therein and also to their IgG(IgG)Fc regions.Recently,we demonstrated that multiple therapeutic human IgG1 antibodies suppress angiogenesis in a target-independent manner via FcγRI,a high-affinity receptor for IgG1.Here we show that IVIg possesses similar anti-angiogenic activity and inhibited blood vessel growth in five different mouse models of prevalent human diseases,namely,neovascular age-related macular degeneration,corneal neovascularization,colorectal cancer,fibrosarcoma and peripheral arterial ischemic disease.Angioinhibition was mediated by the Fc region of IVIg,required FcγRI and had similar potency in transgenic mice expressing human FcγRs.Finally,IVIg therapy administered to humans for the treatment of inflammatory or autoimmune diseases reduced kidney and muscle blood vessel densities.These data place IVIg,an agent approved by the US Food and Drug Administration,as a novel angioinhibitory drug in doses that are currently administered in the clinical setting.In addition,they raise the possibility of an unintended effect of IVIg on blood vessels.Reo Yasuma Valeria Cicatiello Takeshi Mizutani Laura Tudisco Younghee Kim Valeria Tarallo Sasha Bogdanovich Yoshio Hirano Nagaraj Kerur Shengjian Li Tetsuhiro Yasuma Benjamin J Fowler Charles B Wright Ivana Apicella Adelaide Greco Arturo Brunetti Balamurali K Ambati Sevim Barbasso Helmers Ingrid E Lundberg Ondrej Viklicky Jeanette HW Leusen J Sjef Verbeek Bradley D Gelfand Ana Bastos-Carvalho Sandro De Falco Jayakrishna Ambati 2016Signal Transduction and Targeted Therapy2016,1,1:3
4Meeting report:a hard look at the state of enamel research显示文摘The Encouraging Novel Amelogenesis Models and Ex vivo cell Lines(ENAMEL) Development workshop was held on 23 June 2017 at the Bethesda headquarters of the National Institute of Dental and Craniofacial Research(NIDCR). Discussion topics included model organisms, stem cells/cell lines, and tissues/3 D cell culture/organoids. Scientists from a number of disciplines,representing institutions from across the United States, gathered to discuss advances in our understanding of enamel, as well as future directions for the field.ophir d klein olivier duverger wendy shaw rodrigo s lacruz derk joester janet moradian-oldak megan k pugach j timothy wright sarah e millar ashok b kulkarni john d bartlett thomas gh diekwisch pamela den besten james p simmer 2017International Journal of Oral Science2017,9,4:3
5Immunohistochemical analysis of the Wnt/β-catenin signaling pathway in pancreatic neuroendocrine neoplasms显示文摘AIM: To investigate the role of the Wnt/β-catenin pathway in pancreatic neuroendocrine neoplasms(PanN ENs). METHODS: Tissue microarrays containing 88 PanN ENs were immunohistochemically labeled with antibodies to β-catenin, E-cadherin, adenomatous polyposis coli(APC), chromogranin and synaptophysin. One case had only metastatic tumors resected, whereas others(n = 87) received pancreatectomy with or without partial hepatectomy. Pathology slides, demographic, clinicopathologic, and follow up data were reviewed. Patients' demographics, clinicopathologic features, and immunohistochemical results from 87 primary tumors were compared between patients with low stage(stage Ⅰ/Ⅱ) and high stage(stage Ⅲ/Ⅳ) tumors. In addition, correlation of immunohistochemical results from primary tumors with disease-specific survival(DSS) was evaluated. RESULTS: Strong membranous β-catenin staining in the primary tumor was observed in all 13 stage Ⅲ/Ⅳ Pan NENs as compared to 47%(35/74) of stage Ⅰ/Ⅱtumors(P < 0.01). However, the strong membranous β-catenin staining was unassociated with tumor grade or DSS. Decreased membranous β-catenin staining was associated with decreased membranous E-cadherin labeling. Nuclear β-catenin staining was seen in 15%(2/13) of stage Ⅲ/Ⅳ Pan NENs as compared to 0%(0/74) of stage Ⅰ/Ⅱ tumors(P = 0.02). The case with metastasectomy only also showed nuclear β-catenin staining. Two of the three cases with nuclear β-catenin staining were familial adenomatous polyposis(FAP) patients. Lack of APC expression was seen in 70%(57/81) of the cases, including the 3 cases with nuclear β-catenin staining. Expression of E-cadherin and APC in primary tumor was not correlated with tumor grade, tumor stage, or disease specific survival. CONCLUSION: The Wnt/β-catenin pathway was altered in some PanN ENs, but did not Impact DSS. PanN ENs in FAP patients demonstrated nuclear β-catenin accumulation and loss of APC.Vivian Weiss Julie Dueber Jesse P Wright Justin Cates Frank Revetta Alexander A Parikh Nipun B Merchant Chanjuan Shi 2016World Journal of Gastrointestinal Oncology2016,8,8:3
6Fretting wear and cracking in sintered metal matrix composites显示文摘Martin B Vincent L Wright C S 2001Wear2001,248,1:2
7Racial differences in effectiveness of α-fetoprotein for diagnosis of hepatocellular carcinoma in hepatitis C virus cirrhosis显示文摘Mindie H Nguyen Ruel T Garcia Peter W Simpson Teresa L Wright Emmet B Keeffe 2002Hepatology2002,,2:2
8Synthesis and DNA binding of spiroeyelic model compounds related to the neocarzinostatin chromophore 显示文摘Xi Z Jones G B Qabaja G Wright J Johnson F Goldberg I H 1999Org Lett1999,1,9:1
9Differential scanning calorimetric studies of muscle and its constituent proteins 显示文摘Wright D J Leach I B Wilding P 1977Journal of the Science of Food and Agriculture1977,28,:1
10Efficient linkage discovery by limited probing 显示文摘HECKENDORN R B WRIGHT A 2004Evolutionary Computation2004,12,4:1
11Storm wave reactivation of a submarine landslide显示文摘Prior D B Suhayda J N Lu N J Bomhold B D Keller G H Wiseman W J Wright L D Yang Z S 1989Nature1989,341,:1
12Evidence for Eocene mafic underplating, during fore-arc intrusive activity, eastern Chugach Mountains, Alaska显示文摘HARRIS N R SISSON V B WRIGHT J E 1996Geology1996,24,:1
13Molecular diversity of rumen methanogens from sheep in Western Australia显示文摘Wright A D G Williams A J Winder B 2004Appllied Environmental Microbiology2004,70,3:1
14A gene expression based method to diagnose clinically distinct subgroups of dif fuse large B cell lymphoma显示文摘Wright G Tan B Rosenwald A el al 2003Proc Natl Acad Sci USA2003,100,17:1
15Corrosin of Iron in an H2S- CO2-H20 System显示文摘Greco Edward C William B Wright 1962Corrosion1962,18,:1
16Understanding Rasch measurement:Rasch models overview显示文摘Wright B D Mok M 2000Journal of Applied Measure- ment2000,,1:1
17Reduction in hyperam- monaemia by ornithine phenylacetate prevents lipopolysaccharide- induced brain edema and coma in cirrhotic rats 显示文摘Wright G Vairappan B Stadlbauer V 2012Liver Interna- tional2012,32,:1
18Fundamental trade-offs generating the worldwide leaf economics spectrum 显示文摘Shipley B Lechowicz M J Wright I J 2006Ecology2006,87,:1
19Corporate Governance and Market Valuation of Capital and RD Investments显示文摘Chung K Wright P Kedia B 2003Review of Finan- cial Economics2003,,12:1
20A low-field, low-cost Halbach magnet array for open-access NMR显示文摘Hills B P Wright K M Gilles D G 2005Journal of Magnetic Resonance2005,175,:1
返回顶部 每页显示:
共89页 首页 上一页 第1页 下一页 末页 /89 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费